Literature DB >> 31847979

The effect of the blended education program on treatment concordance of patients with hypertension: A single-blind randomized, controlled trial.

Nader Aghakhani1, Naser Parizad2, Behrouz Soltani3, Kamal Khademvatan1, Zahra Rahimi4.   

Abstract

Poor treatment concordance is one of the major problems in patients with hypertension (HTN). An appropriate teaching method can help solving this problem. This study aimed to determine the effect of blended education program on treatment concordance in patients with HTN. This is a single-blind randomized controlled trial, and 60 patients with HTN who met inclusion criteria were selected by a convenience sampling and allocated into the control and intervention groups. A demographic information form and the questionnaires were used in this study. The questionnaires included questions addressing treatment concordance, which explored three dimensions: dietary adherence, medication adherence, physical activity plan. The blended educational intervention was carried out for 4 weeks in the intervention group. The control group only received traditional face-to-face education. The results showed that there was a significant increase in the total score of treatment concordance of the intervention group compared to the control group after the intervention (P < .001). In conclusion, using a blended education program is highly recommended to improve treatment concordance in patients with HTN. Consequently, it reduces patients' medical costs and enhances their health-related quality of life.
Copyright © 2019 Society for Vascular Nursing. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31847979     DOI: 10.1016/j.jvn.2019.08.001

Source DB:  PubMed          Journal:  J Vasc Nurs        ISSN: 1062-0303


  1 in total

1.  Addition of the Electronic Educational Material to Doctor's Face-to-Face Education Has No Additive Effects on Hypertension Control: A Randomized Single Blind Study.

Authors:  John Yang Lee; Dihua Tang; Xinhua Xiao; Xiaoping Liang; Huihon Piao; Mian Xie
Journal:  Int J Hypertens       Date:  2020-09-15       Impact factor: 2.420

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.